Eli Lilly (LLY) shares snapped six straight days of losses as the stock closed 1.39% higher, at $812.76 on Friday. The ...

The world grapples with multiple health challenges, from Nigeria's Lassa fever outbreak to the WHO adjusting to U.S. funding cuts. Amid these global health issues, the U.S. addresses domestic and ...

Weight loss injectables like Ozempic have gained popularity in Bengaluru, with patients sourcing them from abroad. The ...

Companies like Novo Nordisk, Boeing, and Walmart are preparing for the impacts of President Donald Trumps tariffs. Executives ...

Homegrown pharmaceutical companies launching significantly cheaper generic versions of empagliflozin—a widely prescribed SGLT2 inhibitor for type-2 diabetes ...

The companies in question, Dr. Reddy’s Laboratories, Sun Pharma and Zydus Pharmaceuticals, are recalling seizure treatments, ...

The agreement covering the compound petrelintide, announced by Roche on Wednesday, marks renewed efforts to catch up with weight-loss market leaders Novo Nordisk and Eli Lilly .

Companies in the US, including Novo Nordisk, Boeing and Shein, are forming task forces to address the impact of Donald ...

Pharma firms are among many pausing diversity programmes and promising domestic investment ...

President Trump threatened to impose a 200% tariff on EU wines and champagne unless the EU rescinds its 50% tax on US alcohol ...

Discover last week's top S&P 500 healthcare gainers, major market stories, and groundbreaking pharma deals, including weight-loss drug updates.